Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Breast Neoplasms 46Neoplasms 10Prostatic Neoplasms 8Unspecified Adult Solid Tumor, Protocol Specific 6Neoplasm Metastasis 6Carcinoma, Ovarian Epithelial 5Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms, Male 5Sarcoma 4Ovarian Neoplasms 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Stomach Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Lung Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Kidney Neoplasms 3Endometrial Neoplasms 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Burkitt Lymphoma 3Wilms Tumor 2Testicular Neoplasms 2Teratoma 2

Interventions

Cisplatin 12Etoposide 11Carboplatin 9Paclitaxel 7Ifosfamide 7Filgrastim 7Bleomycin 6Radiotherapy 5Magnetic Resonance Spectroscopy 4pegfilgrastim 3Peripheral Blood Stem Cell Transplantation 3liposomal amphotericin B 2Therapeutics 2Platinum 2Ipilimumab 2Imatinib Mesylate 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2CTLA-4 Antigen 2tremelimumab 1sodium thiosulfate 1sargramostim 1lerisetron 1ixabepilone 1etoposide phosphate 1durvalumab 1cabozantinib 1aldesleukin 1Vinblastine 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Seminoma × ixabepilone × Clear all
NCT00070096 2013-06-24

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

National Cancer Institute (NCI)

Phase 2 Completed
29 enrolled
CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡